Digital brain training may ease 'chemo brain' — a trial puts it to the test

NCT ID NCT07729969

Recruiting now Symptom relief Sponsor: Biogipuzkoa Health Research Institute Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether two types of home-based digital cognitive training can help cancer survivors who have memory, attention, or thinking problems after chemotherapy. Participants will use either a computer program (BrainHQ) or a virtual reality cognitive training for 10 weeks. The study compares these interventions to a control group to see which approach is most effective and user-friendly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: computerized cognitive training via BrainHQ program
What this could lead to: If effective, this could offer a convenient, home-based way to ease cognitive difficulties after cancer treatment.
What could go wrong: This is a relatively small, early-stage trial. The cognitive benefits may be modest or not translate to real-world improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Cognitive Dysfunction neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER COGNITIVE CHANGE COGNITIVE IMPAIRMENT

Contacts and locations

Locations

Hospital Universitario Basurto
RECRUITING

Bilbao, Bizkaia, 48013, Spain
Hospital Universitario Donostia
RECRUITING

San Sebastián, Gipuzkoa, 20014, Spain
Hospital Universitario Galdakao-Usansolo
RECRUITING

Galdakao, Bizkaia, 48960, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.